Status:
COMPLETED
Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET
Lead Sponsor:
Technische Universität Dresden
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of the study is to describe the regional and global FDG-kinetics in head and neck cancer during percutaneous radiation therapy.
Eligibility Criteria
Inclusion
- Histologically confirmed head and neck cancer not curable by surgery
- Karnofsky \> 70%
- Tumor volume and localization allow curative radiotherapy
- Written consent
Exclusion
- Metastases
- Earlier radiotherapy of head or neck
- Pregnancy
- Secondary malignancy excluding dermal carcinoma T1 and Tis-carcinoma of cervix uteri
- Psychiatric impairment
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00180245
Start Date
July 1 2005
End Date
December 1 2015
Last Update
March 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nuclear Medicine
Dresden, Germany, 01307